Exacerbations in chronic obstructive pulmonary disease (COPD) are major contributors to worsening lung function, impaired quality of life, emergency healthcare use and COPD-related mortality. COPD exacerbations are heterogeneous in terms of airway inflammation and aetiology. About 60% of COPD patients have blood eosinophil counts of ≥2%, which appears to be associated with an increased risk of exacerbations [1–3]. However, the association between blood eosinophil counts at stable disease and COPD exacerbations in the subsequent year is incompletely understood.

Blood eosinophil count and exacerbation risk in patients with COPD

PAPI, Alberto;
2017

Abstract

Exacerbations in chronic obstructive pulmonary disease (COPD) are major contributors to worsening lung function, impaired quality of life, emergency healthcare use and COPD-related mortality. COPD exacerbations are heterogeneous in terms of airway inflammation and aetiology. About 60% of COPD patients have blood eosinophil counts of ≥2%, which appears to be associated with an increased risk of exacerbations [1–3]. However, the association between blood eosinophil counts at stable disease and COPD exacerbations in the subsequent year is incompletely understood.
2017
Kerkhof, Marjan; Sonnappa, Samatha; Postma, Dirkje S.; Brusselle, Guy; Agustã­, Alvar; Anzueto, Antonio; Jones, Rupert; Papi, Alberto; Pavord, Ian; Pi...espandi
File in questo prodotto:
File Dimensione Formato  
1700761.full.pdf

accesso aperto

Descrizione: Full text editoriale
Tipologia: Full text (versione editoriale)
Licenza: PUBBLICO - Pubblico con Copyright
Dimensione 368.57 kB
Formato Adobe PDF
368.57 kB Adobe PDF Visualizza/Apri

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2375577
Citazioni
  • ???jsp.display-item.citation.pmc??? 39
  • Scopus 72
  • ???jsp.display-item.citation.isi??? 54
social impact